You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Absorbable and Low-Cost Radioseeds for Malignant Tumors

    SBC: XL Sci Tech Inc            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this Phase I research is to demonstrate the feasibility of creating timed-bioabsorbable Pd-103 seeds for the treatment of prostate tumors. Timed- bioabsorbable seeds have the combined benefits of titanium seeds, high dose rate temporary seeds, external beam radiation and other treatment options. In addition, timed-bioabsorbable seeds potentiall ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  2. A Continuous Monitor for Arsenic in Drinking Water

    SBC: TraceDetect, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): TraceDetect aims to develop a stand-alone electrochemical instrument with performance that is comparable to or better than most atomic spectroscopic detectors currently used for the determination of arsenic in waters. This instrument will also constantly monitor the concentration of arsenic in any fluid stream. We have designed an on-line pretreatment system an ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  3. ADAPTING EXISTING CURRICULA FOR PROMOTING SOCIAL AND ADA

    SBC: THREE C INSTITUTE FOR SOCIAL DEVELOPMT            Topic: N/A

    Location 1903 N HARRISON AVE, STE 101 CARY, NC 27513 United States N44MH0664102C $365 147.00 2 005 ADAPTING EXISTING CURRICULA FOR PROMOTING SOCIAL AND ADA Department of Health and Human Services National Institutes of Health SBIR PHS2006-1 THREE C INSTIT ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  4. Adipose Derived Adult Stem Cells in Hepatic Regeneration

    SBC: VESTA THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Liver failure secondary to hepatitis, hepatotoxin exposure, and cirrhosis threatens the lives of thousands in the United States alone. Estimates of yearly direct healthcare costs for liver disease in the U.S. range from $60 billion to over $100 billion. Vesta Therapeutics has developed proprietary technologies for the isolation and preservation of primary hepat ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  5. Administrator's Guide to RY Implementation

    SBC: RECONNECTING YOUTH COMPANY            Topic: N/A

    DESCRIPTION (provided by applicant): Our long-term goal is to enhance the implementation fidelity of Reconnecting Youth [RY(r)], a NIH/SAMSHA model prevention program. Implementation failures of model programs include unrecognized, persistent structural features, poor management, meager attention paid to the adults who lead and carry out the program. Hence, we focus on innovative ways to prepare a ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  6. Administrator's Guide to RY Implementation

    SBC: RECONNECTING YOUTH COMPANY            Topic: N/A

    DESCRIPTION (provided by applicant): Our long-term goal is to enhance the implementation fidelity of Reconnecting Youth [RY(r)], a NIH/SAMSHA model prevention program. Implementation failures of model programs include unrecognized, persistent structural features, poor management, meager attention paid to the adults who lead and carry out the program. Hence, we focus on innovative ways to prepare a ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  7. Advanced Technology for Administration of the Teen-ASI

    SBC: Health Outcomes Inc            Topic: N/A

    DESCRIPTION (provided by applicant): We propose to conduct a clinical trial using a suite of web-based software products as well as a web portal that will help with standardized assessment, treatment planning, referral, and outcomes tracking for adolescent substance abuse treatment. Products will include the automated Internet version of the Self- Report Teen-Addiction Severity Index (SR-T-ASI Net ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  8. All Stars Technology: Web-Based Program Enhancements

    SBC: TANGLEWOOD RESEARCH INC            Topic: N/A

    DESCRIPTION (provided by applicant): The success of research-based prevention programs depends on the degree to which they are implemented with fidelity. This Phase II project will enhance All Stars, a drug abuse prevention program, by integrating web-based and multimedia technologies. Enhancements will improve program fidelity by making the program easier to deliver. They will improve effectivene ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  9. Alzheimer's Therapeutic Derived from a Natural Product

    SBC: ICOGENEX CORPORATION            Topic: N/A

    DESCRIPTION (PROVIDED BY APPLICANT): This proposal seeks funding for the development of an Alzheimer's disease (AD) therapeutic using an innovative approach to develop a pharmaceutical that can be used as both a treatment and as a preventative. AD is a devastating common disorder affecting primarily elderly people with a frequency of 5% of the population over 65, increasing to 20% over 80 and 50 % ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  10. Aminotrexate A Novel Strategy to Replace Methotrexate in Psoriasis

    SBC: Syntrix Biosystems, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Aminotrexate(tm) (AMT) is an antifolate in the same class as MIX that we have established is nearly 100% orally bioavailable in humans with a lower interpatient coefficient of variation than MTX, and is much more rapidly taken up by cells and tissues. With regard to non-CNS toxicities and response to the antidote leucovorin, AMT is indistinguishable from MTX. A ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government